Recent advances in PLGA particulate systems for drug delivery (original) (raw)
Acharya S, Sahoo SK (2011) PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev 63:170–183 ArticlePubMedCAS Google Scholar
Acharya S, Dilnawaz F, Sahoo SK (2009) Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. Biomaterials 30:5737–5750 ArticlePubMedCAS Google Scholar
Agnihotri SM, Vavia PR (2009) Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application. Nanomed Nanotechnol Biol Med 5:90–95 ArticleCAS Google Scholar
Aguiar MMG, Rodrigues JM, Silva Cunha A (2004) Encapsulation of insulin–cyclodextrin complex in PLGA microspheres: a new approach for prolonged pulmonary insulin delivery. J Microencapsul 21:553–564 ArticlePubMedCAS Google Scholar
Ali Y, Lehmussaari K (2006) Industrial perspective in ocular drug delivery. Adv Drug Deliv Rev 58:1258–1268 ArticlePubMedCAS Google Scholar
Araújo J, Vega E, Lopes C, Egea MA, Garcia ML, Souto EB (2009) Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres. Colloids Surf B 72:48–56 Article Google Scholar
Aravind A, Varghese S, Veeranarayanan S, Mathew A, Nagaoka Y, Iwai S, Fukuda T, Hasumura T, Yoshida Y, Maekawa T, Kumar D (2012) Aptamer-labeled PLGA nanoparticles for targeting cancer cells. Cancer Nanotechnol. doi:10.1007/s12645-011-0024-6 Google Scholar
Arruebo M, Valladares M, Gonzalez-Fernandez A (2009) Antibody-conjugated nanoparticles for biomedical applications. J Nanomater 2009:1–24 Article Google Scholar
Badawi A, El-Laithy H, El Qidra R, El Mofty H, El dally M (2008) Chitosan based nanocarriers for indomethacin ocular delivery. Arch Pharmacal Res 31:1040–1049 ArticleCAS Google Scholar
Balamurugan S, Obubuafo A, Soper S, Spivak D (2008) Surface immobilization methods for aptamer diagnostic applications. Anal Bioanal Chem 390:1009–1021 ArticlePubMedCAS Google Scholar
Beck-Broichsitter M, Merkel OM, Kissel T (2012) Controlled pulmonary drug and gene delivery using polymeric nano-carriers. J Control Release. doi:10.1016/j.jconrel.2011.12.004
Bhavane R, Karathanasis E, Annapragada AV (2003) Agglomerated vesicle technology: a new class of particles for controlled and modulated pulmonary drug delivery. J Control Release 93:15–28 ArticlePubMedCAS Google Scholar
Bivas-Benita M, Romeijn S, Junginger HE, Borchard G (2004) PLGA–PEI nanoparticles for gene delivery to pulmonary epithelium. Eur J Pharm Biopharm 58:1–6 ArticlePubMedCAS Google Scholar
Bivas-Benita M, Lin MY, Bal SM, van Meijgaarden KE, Franken KLMC, Friggen AH, Junginger HE, Borchard G, Klein MR, Ottenhoff THM (2009) Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA–PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice. Vaccine 27:4010–4017 ArticlePubMedCAS Google Scholar
Blum J, Weller C, Booth C, Babar I, Liang X, Slack F, Saltzman W (2011) Prevention of _K_-_Ras_- and _Pten_-mediated intravaginal tumors by treatment with camptothecin-loaded PLGA nanoparticles. Drug Deliv Transl Res 1:383–394 ArticleCAS Google Scholar
Brigger I, Dubernet C, Couvreur P (2002) Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 54:631–651 ArticlePubMedCAS Google Scholar
Brooks P, Clark R, Cheresh D (1994) Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264:569–571 ArticlePubMedCAS Google Scholar
Carino GP, Jacob JS, Mathiowitz E (2000) Nanosphere based oral insulin delivery. J Control Release 65:261–269 ArticlePubMedCAS Google Scholar
Champion JA, Katare YK, Mitragotri S (2007) Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. J Control Release 121:3–9 ArticlePubMedCAS Google Scholar
Chang E, McClellan AJ, Farley WJ, Li D-Q, Pflugfelder SC, De Paiva CS (2011) Biodegradable PLGA-based drug delivery systems for modulating ocular surface disease under experimental murine dry eye. J Clin Exp Ophthalmol 2:1–6 Google Scholar
Coowanitwong I, Arya V, Kulvanich P, Hochhaus G (2008) Slow release formulations of inhaled rifampin. AAPS J 10:342–348 ArticlePubMedCAS Google Scholar
Cu Y, Booth CJ, Saltzman WM (2011) In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery. J Control Release 156:258–264 ArticlePubMedCAS Google Scholar
Damgé C, Michel C, Aprahamian M, Couvreur P, Devissaguet JP (1990) Nanocapsules as carriers for oral peptide delivery. J Control Release 13:233–239 Article Google Scholar
Danhier F, Vroman B, Lecouturier N, Crokart N, Pourcelle V, Freichels H, Jérôme C, Marchand-Brynaert J, Feron O, Préat V (2009) Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with Paclitaxel. J Control Release 140:166–173 ArticlePubMedCAS Google Scholar
De Stefano D, Ungaro F, Giovino C, Polimeno A, Quaglia F, Carnuccio R (2011) Sustained inhibition of IL-6 and IL-8 expression by decoy ODN to NF-κB delivered through respirable large porous particles in LPS-stimulated cystic fibrosis bronchial cells. J Gene Med 13:200–208 ArticlePubMed Google Scholar
des Rieux A, Fievez V, Garinot M, Schneider YJ, Préat V (2006) Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release 116:1–27 ArticlePubMedCAS Google Scholar
Dhar S, Gu FX, Langer R, Farokhzad OC, Lippard SJ (2008) Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticles. Proc Natl Acad Sci USA 105:17356–17361 ArticlePubMedCAS Google Scholar
Di Toro R, Betti V, Spampinato S (2004) Biocompatibility and integrin-mediated adhesion of human osteoblasts to poly(dl-lactide-co-glycolide) copolymers. Eur J Pharm Sci 21:161–169 ArticlePubMed Google Scholar
Dong Y, Feng S–S (2005) Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Biomaterials 26:6068–6076 ArticlePubMedCAS Google Scholar
Edwards DA, Ben-Jebria A, Langer R (1998) Recent advances in pulmonary drug delivery using large, porous inhaled particles. J Appl Physiol 85:379–385 PubMedCAS Google Scholar
Emami J, Hamishehkar H, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Mirzadeh H, Fakhari A, Nokhodchi A (2009) Particle size design of PLGA microspheres for potential pulmonary drug delivery using response surface methodology. J Microencapsul 26:1–8 ArticlePubMedCAS Google Scholar
Ensign LM, Cone R, Hanes J (2012) Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliv Rev 64:557–570 Google Scholar
Evora C, Soriano I, Rogers RA, Shakesheff KM, Hanes J, Langer R (1998) Relating the phagocytosis of microparticles by alveolar macrophages to surface chemistry: the effect of 1,2-dipalmitoylphosphatidylcholine. J Control Release 51:143–152 ArticlePubMedCAS Google Scholar
Gavini E, Chetoni P, Cossu M, Alvarez MG, Saettone MF, Giunchedi P (2004) PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies. Eur J Pharm Biopharm 57:207–212 ArticlePubMedCAS Google Scholar
Gref R, Minamitake Y, Peracchia M, Trubetskoy V, Torchilin V, Langer R (1994) Biodegradable long-circulating polymeric nanospheres. Science 263:1600–1603 ArticlePubMedCAS Google Scholar
Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G (2010) Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomed Nanotechnol Biol Med 6:324–333 ArticleCAS Google Scholar
Ham A, Cost M, Sassi A, Dezzutti C, Rohan L (2009) Targeted delivery of PSC-RANTES for HIV-1 prevention using biodegradable nanoparticles. Pharm Res 26:502–511 ArticlePubMedCAS Google Scholar
Hamishehkar H, Emami J, Najafabadi AR, Gilani K, Minaiyan M, Hassanzadeh K, Mahdavi H, Koohsoltani M, Nokhodchi A (2010) Pharmacokinetics and pharmacodynamics of controlled release insulin loaded PLGA microcapsules using dry powder inhaler in diabetic rats. Biopharm Drug Dispos 31:189–201 PubMedCAS Google Scholar
Hara K, Tsujimoto H, Tsukada Y, Huang CC, Kawashima Y, Tsutsumi M (2008) Histological examination of PLGA nanospheres for intratracheal drug administration. Int J Pharm 356:267–273 ArticlePubMedCAS Google Scholar
Italia J, Yahya M, Singh D, Ravi Kumar M (2009) Biodegradable nanoparticles improve oral bioavailability of amphotericin B and show reduced nephrotoxicity compared to intravenous Fungizone®. Pharm Res 26:1324–1331 ArticlePubMedCAS Google Scholar
Jain GK, Pathan SA, Akhter S, Jayabalan N, Talegaonkar S, Khar RK, Ahmad FJ (2011) Microscopic and spectroscopic evaluation of novel PLGA–chitosan nanoplexes as an ocular delivery system. Colloids Surf B 82:397–403 ArticleCAS Google Scholar
Jensen DK, Jensen LB, Koocheki S, Bengtson L, Cun D, Nielsen HM, Foged C (2012) Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA. J Control Release 157:141–148 ArticlePubMedCAS Google Scholar
Kalaria D, Sharma G, Beniwal V, Ravi Kumar M (2009) Design of biodegradable nanoparticles for oral delivery of doxorubicin: in vivo pharmacokinetics and toxicity studies in rats. Pharm Res 26:492–501 ArticlePubMedCAS Google Scholar
Kawashima Y, Yamamoto H, Takeuchi H, Fujioka S, Hino T (1999) Pulmonary delivery of insulin with nebulized dl-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect. J Control Release 62:279–287 ArticlePubMedCAS Google Scholar
Lai SK, Wang Y-Y, Hida K, Cone R, Hanes J (2010) Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses. Proc Natl Acad Sci USA 107:598–603 ArticlePubMedCAS Google Scholar
Lee CH, Moturi V, Lee Y (2009) Thixotropic property in pharmaceutical formulations. J Control Release 136:88–98 ArticlePubMedCAS Google Scholar
Levy-Nissenbaum E, Radovic-Moreno AF, Wang AZ, Langer R, Farokhzad OC (2008) Nanotechnology and aptamers: applications in drug delivery. Trends Biotechnol 26:442–449 ArticlePubMedCAS Google Scholar
Luo G, Yu X, Jin C, Yang F, Fu D, Long J, Xu J, Zhan C, Lu W (2010) LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors. Int J Pharm 385:150–156 ArticlePubMedCAS Google Scholar
McCarron PA, Marouf WM, Quinn DJ, Fay F, Burden RE, Olwill SA, Scott CJ (2008) Antibody targeting of camptothecin-loaded PLGA nanoparticles to tumor cells. Bioconjug Chem 19:1561–1569 ArticlePubMedCAS Google Scholar
Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar MNV (2007) Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Control Release 119:77–85 ArticlePubMedCAS Google Scholar
Nagarwal RC, Kant S, Singh PN, Maiti P, Pandit JK (2009) Polymeric nanoparticulate system: a potential approach for ocular drug delivery. J Control Release 136:2–13 ArticlePubMedCAS Google Scholar
Panyam J, Zhou W-Z, Prabha S, Sahoo SK, Labhasetwar V (2002) Rapid endo-lysosomal escape of poly(dl-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J 16:1217–1226 ArticlePubMedCAS Google Scholar
Patil Y, Sadhukha T, Ma L, Panyam J (2009a) Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance. J Control Release 136:21–29 ArticlePubMedCAS Google Scholar
Patil YB, Toti US, Khdair A, Ma L, Panyam J (2009b) Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery. Biomaterials 30:859–866 ArticlePubMedCAS Google Scholar
Patil YB, Swaminathan SK, Sadhukha T, Ma L, Panyam J (2010) The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance. Biomaterials 31:358–365 ArticlePubMedCAS Google Scholar
Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2:751–760 ArticlePubMedCAS Google Scholar
Pérez C, Griebenow K (2003) Effect of salts on lysozyme stability at the water–oil interface and upon encapsulation in poly(lactic-co-glycolic) acid microspheres. Biotechnol Bioeng 82:825–832 ArticlePubMed Google Scholar
Rogers SJ, Harrington KJ, Rhys-Evans P, O-Charoenrat P, Eccles SA (2005) Biological significance of c-erbB family oncogenes in head and neck cancer. Cancer Metastasis Rev 24:47–69 ArticlePubMedCAS Google Scholar
Sahoo SK, Labhasetwar V (2005) Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol Pharm 2:373–383 ArticlePubMedCAS Google Scholar
Shaikh J, Ankola DD, Beniwal V, Singh D, Kumar MNVR (2009) Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci 37:223–230 ArticlePubMedCAS Google Scholar
Song XR, Cai Z, Zheng Y, He G, Cui FY, Gong DQ, Hou SX, Xiong SJ, Lei XJ, Wei YQ (2009) Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles. Eur J Pharm Sci 37:300–305 ArticlePubMedCAS Google Scholar
Suarez S, O’Hara P, Kazantseva M, Newcomer CE, Hopfer R, McMurray DN, Hickey AJ (2001) Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model. Pharm Res 18:1315–1319 ArticlePubMedCAS Google Scholar
Sun S, Cui F, Kawashima Y, Liang N, Zhang L, Shi K, Yu Y (2008) A novel insulin-sodium oleate complex for oral administration: preparation, characterization and in vivo evaluation. J Drug Deliv Sci Technol 18:239–243 CAS Google Scholar
Sun S, Liang N, Piao H, Yamamoto H, Kawashima Y, Cui F (2010) Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluation. J Microencapsul 27:471–478 ArticlePubMedCAS Google Scholar
Sung JC, Pulliam BL, Edwards DA (2007) Nanoparticles for drug delivery to the lungs. Trends Biotechnol 25:563–570 ArticlePubMedCAS Google Scholar
Ungaro F, De Rosa G, Miro A, Quaglia F, La Rotonda MI (2006) Cyclodextrins in the production of large porous particles: development of dry powders for the sustained release of insulin to the lungs. Eur J Pharm Sci 28:423–432 ArticlePubMedCAS Google Scholar
Ungaro F, di Villa d’Emmanuele, Bianca R, Giovino C, Miro A, Sorrentino R, Quaglia F, LaRotonda MI (2009) Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs. J Control Release 135:25–34 ArticlePubMedCAS Google Scholar
Ungaro F, d’Angelo I, Coletta C, d’Emmanuele di Villa Bianca R, Bianca R, Sorrentino R, Perfetto B, Tufano MA, Miro A, La Rotonda MI, Quaglia F (2012) Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers. J Control Release 157:149–159 ArticlePubMedCAS Google Scholar
Vega E, Gamisans F, García ML, Chauvet A, Lacoulonche F, Egea MA (2008) PLGA nanospheres for the ocular delivery of flurbiprofen: drug release and interactions. J Pharm Sci 97:5306–5317 ArticlePubMedCAS Google Scholar
Whaley KJ, Hanes J, Shattock R, Cone RA, Friend DR (2010) Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines. Antiviral Res 88(Supplement):S55–S66 ArticlePubMedCAS Google Scholar
Wu X (1995) Synthesis and properties of biodegradable lactic/glycolic acid polymers. In: Wise DL, Trantolo DJ, Altobelli DE, Yaszemski MJ, Gresser JD, Schwartz ER (eds) Encyclopedic handbook of biomaterials and bioengineering. Part A. Materials, vol 2. Marcel Dekker, New York, pp 1015–1054 Google Scholar
Wu ZM, Zhou L, Guo XD, Jiang W, Ling L, Qian Y, Luo KQ, Zhang LJ (2012) HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin. Int J Pharm 425:1–8 ArticlePubMedCAS Google Scholar
Yoo J-W, Mitragotri S (2010) Polymer particles that switch shape in response to a stimulus. Proc Nat Acad Sci USA 107:11205–11210 ArticlePubMedCAS Google Scholar
Yoo J-W, Choe E-S, Ahn S-M, Lee CH (2010a) Pharmacological activity and protein phosphorylation caused by nitric oxide-releasing microparticles. Biomaterials 31:552–558 ArticlePubMedCAS Google Scholar
Yoo J-W, Lee J-S, Lee CH (2010b) Characterization of nitric oxide-releasing microparticles for the mucosal delivery. J Biomed Mater Res A 92:1233–1243 PubMed Google Scholar
Yoo J-W, Giri N, Lee CH (2011a) pH-sensitive Eudragit nanoparticles for mucosal drug delivery. Int J Pharm 403:262–267 ArticlePubMedCAS Google Scholar
Yoo J-W, Irvine DJ, Discher DE, Mitragotri S (2011b) Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nat Rev Drug Discov 10:521–535 ArticlePubMedCAS Google Scholar
Zhang S, Zhao B, Jiang H, Wang B, Ma B (2007) Cationic lipids and polymers mediated vectors for delivery of siRNA. J Control Release 123:1–10 ArticlePubMedCAS Google Scholar
Zhang T, Sturgis TF, Youan B-BC (2011) pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission. Eur J Pharm Biopharm 79:526–536 ArticlePubMedCAS Google Scholar
Zhou J, Patel TR, Fu M, Bertram JP, Saltzman WM (2012) Octa-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumors. Biomaterials 33:583–591 ArticlePubMedCAS Google Scholar